The new technology could be used in hospitals, prisons and other settings where medical equipment and personnel are often used.
It would allow doctors to keep their patients warm during longer periods of time, according to the University of Warwick researchers.
Dr J. Michael Collins, a member of the research team and a paediatrician at the university, said it would allow a “more flexible” and “simpler” way to diagnose and treat the condition.
He said that while there were no clinical trials yet, the new technology was a “great first step” in understanding the condition and was also a “very exciting prospect”.
He said the technology could potentially reduce the number of days in hospital and prevent patients from being “lost to the system”.
“We know that when you have an infection, the infection is likely to be concentrated in certain parts of the body,” Dr Collins said.
“If you can get a patient to stay with you and you don’t need to worry about what is going on in their body, you are less likely to have a lot of unnecessary infections.”
The technology would also be able to diagnose certain conditions such as high blood pressure and heart conditions, which are known to affect the flow of blood and oxygen in the body.
The study, published in the journal Science Translational Medicine, involved an in vitro study on mice that were injected with an “injectable virus” into their liver.
Researchers said it was the first time a “vaccine” had been used to treat a new type of viral infection.
“We have to be careful about this,” said Dr Collins.
“In this case, we were injecting a virus into the liver, and we are injecting it into the lungs and the heart.”
He said there were still a lot more questions to be answered about how the new therapy would work and whether it would work in people.
“What are the risks?
Is this something that will make us sick?
Is it safe?”
Dr Collins said there was a lot to be learned from the animal studies.
“This is the first technology to address the issue of how we actually get the virus into our body and how that is transmitted to other people, which is a very important question,” he said.
He also pointed out that some patients would still be reluctant to be seen in the ICU.
“I think it is important to be realistic and say that this could be a very good idea if it works, but it would still have to pass through some safety testing.”
The idea is to start this in the lab and then we will see how it works out.””
It will be a big step forward,” Dr Neil Clark, a professor of epidemiology at the University’s Department of Clinical and Translatic Genetics, told Reuters Health.
He added that the study was just a “first step” and that more work needed to be done to determine how effective the treatment would be.”
It’s a very early stage of understanding how we could potentially treat people who are sick, and that is a really big step.
“Dr Collins and Dr Clark said the study could help the field as a whole.”
While we have a long way to go, we can take this very important first step,” Dr Clark added.”
At the moment we have to understand the virus, and the virus is very difficult to understand.””
If we can figure out how to understand it and make it more efficient, we will then be able start to understand how the virus can be used for other purposes.
“Dr Clark said more work was needed to understand what was causing the viral infection in patients.”
There is a lot we don’t know,” he added.
Dr Collins, who is a member in the Royal College of Surgeons’ International Society of Microbiology (ICMJ) group, said the new vaccine was not meant to be used as a treatment for people with HIV or other infectious diseases.
However, he said there would be benefits to using it for other conditions where the virus had not been identified.”
People with some other conditions are also at risk, because they might be more likely to infect other people with the virus and spread it around,” he told Reuters.”
So we need to understand exactly what is happening in people with these conditions.
“He also said the findings could help researchers understand how virus could spread between people in more complex situations.”
These are really big questions,” he explained.”
And they will take time to answer, but we have been working with other groups to try to figure out what the virus looks like, how it spreads, how the immune system can react to it.